Eris Lifesciences stated that its consolidated net profit increased 12 per cent to Rs 101 crore for the third quarter ended December 2021.
The company stated that the revenue stood at Rs 332 crore in the third quarter of the current fiscal as against Rs 310 crore in the year-ago period, Eris Lifesciences said.
''Our focus on building leadership brands in fast-growing therapies coupled with several patent expiration opportunities will enable us to sustain our growth trajectory,'' stated Eris Lifesciences Chairman & Managing Director Amit Bakshi.
(With inputs from PTI)
India, EU To Hold Next Round Of Free Trade Agreement Talks In September
'Proud Of You Brother': Lewis Hamilton Shares Heartfelt Message To Reece James After Chelsea Beats PSG In FIFA CWC Final
Who Is Shashikant Shinde? Meet New State President Of NCP(SP)
'This Death Is Devastating': Pa Ranjith Shares Condolence Note For Stuntman Mohan Raj Who Died In An Accident On The Sets Of Vettuvam
